TipRanks
Advertisement
Advertisement

DE:4AB Stock Latest News

AbbVie presents long-term RINVOQ data at EADV Congress
The FlyAbbVie presents long-term RINVOQ data at EADV Congress
1d ago
ABBV
AbbVie reports Phase 1 data for ABBV-295
PremiumThe Fly
AbbVie reports Phase 1 data for ABBV-295
3d ago
ABBV
AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart
PremiumThe Fly
AbbVie reports ‘positive’ results from Phase 2 APEX Part B study of zumilokibart
3d ago
ABBV
AbbVie partners with Valkai to apply advanced AI across clinical development
PremiumThe Fly
AbbVie partners with Valkai to apply advanced AI across clinical development
3d ago
ABBV
Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium
PremiumThe Fly
Ginkgo Bioworks, Apheris announce kick off of Antibody Developability Consortium
4d ago
DNA
TAK
AbbVie price target raised to $289 from $282 at BofA
PremiumThe FlyAbbVie price target raised to $289 from $282 at BofA
4d ago
ABBV
AbbVie announces FDA approval of Juvmo to treat Parkinson’s disease
Premium
The Fly
AbbVie announces FDA approval of Juvmo to treat Parkinson’s disease
5d ago
ABBV
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
Premium
Ratings
Analyst Reaffirms Buy Rating on AbbVie, Maintaining $280 Price Target After Strong CERVINO Phase III Data
5d ago
ABBV
AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis
PremiumThe Fly
AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis
11d ago
ABBV
AbbVie, Iambic announce multi-year collaboration
PremiumThe Fly
AbbVie, Iambic announce multi-year collaboration
12d ago
ABBV
AbbVie presents new Vraylar data at Psych Congress 2026
PremiumThe Fly
AbbVie presents new Vraylar data at Psych Congress 2026
15d ago
ABBV
AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement
PremiumThe Fly
AbbVie’s Allergan Aesthetics presents clinical data on skin quality improvement
16d ago
ABBV
Ipsen considers building production site in U.S., WSJ says
PremiumThe FlyIpsen considers building production site in U.S., WSJ says
22d ago
ABBV
AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine
Premium
The Fly
AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine
22d ago
ABBV
AbbVie price target raised to $315 from $300 at HSBC
Premium
The Fly
AbbVie price target raised to $315 from $300 at HSBC
23d ago
ABBV
AbbVie price target raised to $282 from $276 at BofA
PremiumThe Fly
AbbVie price target raised to $282 from $276 at BofA
25d ago
ABBV
AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS
PremiumThe Fly
AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS
29d ago
ABBV
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
PremiumCompany Announcements
AbbVie Closes Apogee Acquisition to Expand Immunology Portfolio
29d ago
8K
ABBV
AbbVie completes acquisition of Apogee for $135.11 per share in cash
PremiumThe Fly
AbbVie completes acquisition of Apogee for $135.11 per share in cash
30d ago
ABBV
APGE
AbbVie’s Allergan expands SkinMedica’s portfolio with Barrier Calming Cream
PremiumThe FlyAbbVie’s Allergan expands SkinMedica’s portfolio with Barrier Calming Cream
1M ago
ABBV
AbbVie submits Skyrizi application to the EMA
Premium
The Fly
AbbVie submits Skyrizi application to the EMA
1M ago
ABBV
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
Premium
The Fly
Trump Trade: Canada rolls out 50% tariffs on U.S. metals
1M ago
AA
MT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >